Have a personal or library account? Click to login
EVALI – why was it mandatory or necessary to study a new disease? Cover

EVALI – why was it mandatory or necessary to study a new disease?

Open Access
|Mar 2020

References

  1. Gilbert H. United States Patent Office. 1965. Accessed December 1, 2019. United States Patent Office 3,200,819 Patented Aug. 17, 1965, Smokeless NON-TOBACCO CIGARETTE Herbert A. Gilbert, 278 McKinley Road, Beaver Falls, Pa. Filed Apr. 17, 1963, Ser. No. 273,624 10 Claims. (C. 128–208).
  2. Health Effects of Cigarette Smoking. (2014, February 6). Centers for Disease Control and Prevention. [Accessed 1st December 2019].
  3. Grana R, Benowitz N, Glantz SA. Background paper on E-cigarettes (electronic nicotine delivery systems). Center for Tobacco Control Research and Education, University of California, San Francisco, a WHO Collaborating Center on Tobacco Control. Prepared for World Health Organization Tobacco Free Initiative. December 2013. [Accessed 1st December 2019].
  4. Elia J. Two Vaping Advisories Released by CDC-Medical News | Physician’s First Watch November 20, 2019.
  5. Korin Miller. What Is EVALI? Symptoms of Vaping-Related Lung Illness May Feel Like the Flu-Medical Definition of EVALI, Written by Doctors – MedicineNet. Available from: https://www.medicinenet.com, Oct 16, 2019.
  6. Navon L, Jones CM, Ghinai I, King BA, Briss PA, Hacker KA, et al. Risk factors for E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) among adults who use E-cigarette, or vaping, products – Illinois, July-October 2019. MMWR Morbidity and Mortality Weekly Report. 2019;68(45): 1034–1039.
  7. Ritchel M. New York State suspects vitamin E may have played a role in vaping illnesses. New York Times. September 5, 2019. Available from: https://www.nytimes.com/2019/11/08/health/vaping-illness-cdc.
  8. Ritchel M, Grady D. What you need to know about vaping-related lung illness. New York Times. September 11, 2019. Available from: https://www.nytimes.com/2019/09/07/health/vaping-lung-illness.html?smid=nytcore-ios-share.
  9. Massey JB, She HS, Pownall HJ. Interaction of vitamin E with saturated phospholipid bilayers. Biochemical and Biophysical Research Communication. 1982;106: 842–847.
  10. Casals C, Cañadas O. Role of lipid ordered/disordered phase coexistence in pulmonary surfactant function. Biochimica et Biophysica Acta. 2012;1818: 2550–2562.
  11. Downs D. Amid Vape Pen Lung Disease Deaths: What Exactly is Vitamin E Oil? Seattle, WA: Leafly; 2019. Available from: https://www.leafly.com/news/health/vape-pen-lung-disease-vitamin-eoil-explained [Google Scholar].
  12. Blount BC, Karwowski MP, Morel-Espinosa M, Rees J, Sosnoff C, Cowan E, et al. Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use–Associated Lung Injury — 10 States, August–October 2019. MMWR Morbidity and Mortality Weekly Report. 2019;68(45): 1040–1041.
  13. CDC. Outbreak of Lung Injury Associated with the Use of E-cigarette, or Vaping, Products. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. Availble from: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html#what-cdc-recommends.
  14. Moritz ED, Zapata LB, Lekiachvili A, Glidden E, et al.; Lung Injury Response Epidemiology/Surveillance Group; Lung Injury Response Epidemiology/Surveillance Task Force. Update: characteristics of patients in a national outbreak of e-cigarette, or vaping, product use–associated lung injuries—United States, October 2019. MMWR Morbidity and Mortality Weekly Report 2019;68: 985–959.
  15. Chatman-Stephens K., Roguski K, Jang Y, Cho P, Jatlaoui TC, Kabbani S, et al. Characteristics of hospitalised and non hospitalised patients in a Nationwide outbreak of E-cigarette or Vaping, Product use-associated lung injuries – United States, November 2019. MMWR Morbidity and Mortality Weekly Report. 2019;68(46): 1076–1080.
  16. Jatlaoui TC, Wiltz JL, Kabbani S, Siegel DA, Koppaka R, Montandon M, et al. Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019-US Department of Health and Human Services/Centers for Disease Control and Prevention. MMWR. 2019;68(46): 1081–1086.
  17. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin–preliminary report. The New England Journal of Medicine. 2019. Epub September 6, 2019. Available from: doi:10.1056/NEJMoa1911614.
  18. Siegel DA, Jatlaoui TC, Koumans EH, Kiernan EA, et al.; Lung Injury Response Clinical Working Group; Lung Injury Response Epidemiology/Surveillance Group. Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury—United States, October 2019. MMWR Morbidity and Mortality Weekly Report. 2019;68: 919–927.
  19. Marcelo Ph. No more menthol cigarettes: New ban on tobacco, vape flavours- November 28, 2019 App. News.
  20. Comite permanent des medicins europeens (CPME) 2019/074 FINAL.
DOI: https://doi.org/10.2478/pneum-2019-0035 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993
Language: English
Page range: 157 - 161
Published on: Mar 31, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open

© 2020 Florin Mihălțan, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.